Endocrinology, Diabetes & Metabolism Case Reports (May 2017)

Euthyroid athyroxinemia – a novel endocrine syndrome

  • Nicholas Woodhouse,
  • Fatima Bahowairath,
  • Omayma Elshafie

DOI
https://doi.org/10.1530/EDM-17-0019
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 3

Abstract

Read online

A 55-year-old female was referred with abnormal thyroid function tests (TFTs); the free thyroxine level (FT4) was undetectable 100 mIU/L respectively at 24 h, The FT4 however remained undetectable throughout. Being on thyroxine 100 μg/day for one month, her FT4 level increased to 15 pmol/L and TSH fell to 0.08 mIU/L. Four years earlier at another hospital, her FT4 level had been low (6.8 pmol/L) with a normal TSH and a raised Tc-99 uptake of 20% (normal<4%). We checked the TFTs and Tc-99 scans in 3 of her children; one was completely normal and 2 had euthyroid with soft lobulated goitres. Their Tc-99 scan uptakes were raised at 17% and 15%, with normal TFTs apart from a low FT4 7.2 pmol/L in the son with the largest thyroid nodule. This is a previously unreported form of dyshormonogenesis in which, with time, patients gradually lose their ability to synthesize thyroxine (T4) but not triiodothyroxine (T3).